Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: MoneyMade who wrote (1554)	2/11/1999 9:37:00 PM
From: Anthony@Pacific	Respond to of 2135

Who shorted it at $15..noone I know..

To: MoneyMade who wrote (1554)	2/11/1999 9:39:00 PM
From: LTK007	Respond to of 2135

MoneyMade said <<ENMD is working on a cure for Cancer...and this is how we repay them.>> Rubbish,Folkman is working on the cure for cancer,not ENMD,and he owns no stock in ENMD. Max90

To: MoneyMade who wrote (1554)	2/11/1999 9:44:00 PM
From: Dave Gore	Respond to of 2135

Who the heck shorted this at $15? What an incredible risk! Well, we all make bad judgements, the trick is to not make them twice. One of the things I learned is to play the odds and only invest when the stock is just too good of a value. Sometimes that means buying at strong support levels, and sometimes that means buying when it has verified it's move by gapping up the next day. With this one, that wasn't necessary. With all the assured PR and verified excitement, this was a no-brainer.